AAAS MemberCentral Content Preview

To continue reading, please Login or Join now.


Another drug trial for Alzheimer's disease fails

August 29, 2012 | Author: AAAS member -- Padmini Rangamani, Postdoctoral fellow, UC Berkeley
Another drug trial for Alzheimer's disease fails

Recently, there have been a few major setbacks in the development of drugs for the treatment of Alzheimer's disease. Two late-stage clinical trials of the monoclonal antibody bapineuzumab failed, and the clinical trial for solanezumab, another antibody drug, did not achieve the desired results.